Litcius/Paper detail

Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease

Paolo Rossato, Helmut Glantschnig, Fabio Canneva, Maria Schuster, Sogué Coulibaly, Gerald Schrenk, Dirk Voelkel, Michael Dockal, Barbara Plaimauer, Hanspeter Rottensteiner, Herbert Gritsch, Enrica Federti, Alessandro Mattè, Lucia De Franceschi, Friedrich Scheiflinger, Werner Hoellriegl

2023Journal of Thrombosis and Haemostasis10 citationsDOIOpen Access PDF

Topics & Concepts

ADAMTS13Von Willebrand factorMedicineImmunologyHypoxia (environmental)InflammationHemolysisSickle cell anemiaHemoglobinPharmacologyInternal medicinePlateletDiseaseChemistryOxygenOrganic chemistryComplement system in diseasesHemoglobinopathies and Related DisordersBlood groups and transfusion